Inapill转发了
Proud to share that my Seed-stage small molecule therapeutics start-up Inapill has been selected for the California Life Sciences (CLS) FAST California advisory program Spring 2025 cohort! As a 1st-time founder from academia spinning out a company based on ideas from my postdoc research on #immunometabolism, I very much look forward to leveraging the vast industry knowledge and expertise of Inapill’s FAST advisors over the next few months. Their gracious mentorship will undoubtedly strengthen our company’s strategic direction as we push to meet our Seed fundraising goals. And if you want to learn more about our 1st-in-class approaches to targeting #immunometabolism for improved treatment of inflammatory and autoimmune diseases, mark your calendars for June 4th - Inapill will pitch at the CLS Innovation Showcase at Bakar Bio Labs (home game!) along with the rest of the stellar FAST Spring 2025 cohort. So grateful for the support General Inception Dalriada Drug Discovery Bakar Bio Labs QB3 Joshua Farahzad Kevin Tharp, Ph.D. Eric Noel, PhD, MSc California Life Sciences (CLS) Shikha Sharma
?? Meet our latest FAST California cohort! ?? These innovative life science startups have been selected for 12 weeks of expert business mentoring through California Life Sciences’ FAST California program. Designed to support early-stage founders, FAST connects groundbreaking startups with top-tier advisors to help accelerate their journey. ?? Congratulations to our newest cohort! Inapill, Kira Bio, Kopra Bio, misogi labs, NeedleGPS, Oro Therapeutics, Phaser Solutions Inc., ResVita Bio, Scudo Biosciences, Simurx, Inc., Takeoff41, and Voyant Bio And a huge thank you to our advisors & sponsors for making this program possible. Learn more about the companies and the program here: https://lnkd.in/gDM497Yb #FASTCalifornia #LifeSciences #Innovation #Startups